查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1912825

主動和被動式上下肢訓練系統市場（按設備、系統、治療方法、患者年齡層、組件、應用和最終用戶分類）—2026年至2032年全球預測

Upper & Lower Limb Active & Passive Training System Market by Device Type, System Type, Therapy Type, Patient Age Group, Component, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 180 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，主動和被動上下肢訓練系統市場價值將達到 17.4 億美元，到 2026 年將成長到 18.4 億美元，到 2032 年將達到 26 億美元，複合年成長率為 5.86%。

關鍵市場統計數據
基準年 2025 17.4億美元
預計年份：2026年 18.4億美元
預測年份 2032 26億美元
複合年成長率 (%) 5.86%

為主動和被動式上下肢訓練系統提供策略背景，深入分析臨床路徑、採購決策和創新投資重點。

本執行摘要為臨床醫生、採購經理、產品開發人員和投資者提供了一份簡潔明了、切實可行的上肢和下肢主動及被動訓練系統現狀概述。透過分析設備和系統分類以及臨床和商業性因素，幫助相關人員快速確立策略方向並確定近期投資重點。報告整合了設備層面的差異化（從非機器人等速設備和振動系統到機器人末端執行器和外骨骼解決方案），以及主動和被動模式下的系統性能，同時重點闡述了各細分領域中診所、居家照護機構和醫院面臨的實際運作情況。

技術創新、以服務為中心的模式和臨床證據的融合如何重新定義肢體復健設備的設計、實施和商業性價值

技術、臨床和交付模式的整合變革正在重塑市場格局，從根本上改變了肢體訓練系統的設計、採購和部署方式。微型致動器和高精度感測器的進步使得以往僅限於醫院環境的緊湊型硬體得以應用，從而加速了對可在診所和居家照護環境中可靠使用的設備的需求。同時，軟體驅動的分析和控制系統正從輔助功能發展成為核心差異化因素，實現封閉回路型治療和遠端監測，從而提高護理的連續性並展現可衡量的長期療效。

檢驗2025 年關稅變化帶來的變化，並考慮了極端訓練系統供應鏈的重組、採購經濟學和國內製造業獎勵。

2025年美國關稅調整為肢體復健系統供應鏈帶來了新的挑戰與機會。其累積影響在硬體密集細分領域最為顯著，這些領域普遍依賴進口致動器、精密感測器和專用機械組件。為此，採購團隊和製造商正在重新調整籌資策略，一些供應商採取近岸外包和雙重採購方式來降低風險，而另一些供應商則重新協商組件規格，以在不影響臨床性能的前提下減輕關稅負擔。

一種將設備架構、治療方式、終端用戶實際情況和組件生態系統連結起來的分層分割框架，用於確定研發和商業化路徑的優先順序。

更精細的細分方法揭示了產品開發和商業性化重點能夠帶來最大臨床和經濟回報的領域。設備類型分類將非機器人系統（以等速設備和振動平台為代表）與機器人解決方案（歸類於末端執行器和外骨骼架構）區分開來。每類設備都有不同的臨床工作流程、資本密集度和服務需求，並且通常在多學科復健方案中發揮互補作用。系統類型分類透過區分主動和被動模式，進一步明確了臨床應用。主動系統強調患者主導的運動和運動功能再訓練，而被動系統則針對輔助關節活動度練習和早期術後復健通訊協定進行了最佳化。

美洲、歐洲、中東和非洲以及亞太地區的區域採用趨勢和監管差異將決定每個市場的商業化和服務策略。

區域趨勢對肢體復健系統的採用模式、監管重點和商業模式有顯著影響，因此需要製定針對特定區域的市場進入和規模化策略。在美洲，整合式醫療服務體系、高度集中的專業復健中心以及人們對居家照護解決方案日益成長的興趣正在塑造市場需求。該地區的支付模式和報銷途徑強調已證實的臨床療效和成本效益，因此，可靠的臨床證據和長期使用指標的重要性日益凸顯。

透過策略夥伴關係實現競爭差異化，這些合​​作夥伴關係結合了整合技術堆疊、服務網路、臨床證據和商業規模。

在肢體訓練系統領域，競爭優勢取決於差異化的技術平台、臨床證據以及提供高利用率和良好患者療效的服務的能力。業界領導企業將嚴謹的臨床檢驗與完善的服務網路和成熟的軟體平台相結合，從而支援數據分析和遠端監測。同時，一群新興的專業創新者正專注於特定的臨床適應症和設備創新，例如緊湊型家用外骨骼和模組化末端執行器單元，以挑戰現有企業在價格、易用性和遠端復健路徑整合方面的不足。

為製造商和供應商提供切實可行的策略性舉措，以擴展模組化平台、拓寬服務範圍並展現臨床價值，同時降低關稅和價值鏈風險。

產業領導者應優先考慮一系列切實可行的舉措，使產品開發與臨床工作流程和支付方預期保持一致，同時在不斷變化的關稅和供應鏈環境中保障利潤。首先，關鍵在於投資模組化架構，使底層硬體平台能夠同時支援主動和被動治療模式，並可逐步升級致動器、感測器和軟體功能。這種方法將加快新治療模組的上市速度，並允許為每個最終用戶（無論是專科診所、醫院復健中心還是居家照護客戶）提供客製化配置。

一項透明的混合方法研究結合了專家訪談、技術設備審查、供應鏈分析和臨床文獻檢驗，確保了研究結果的可靠性。

本執行摘要的研究結合了定性專家對話、嚴謹的二手分析和三角驗證，以確保提供客觀、可操作的見解。主要研究包括對臨床醫生、採購人員、設備工程師和醫療系統管理人員進行結構化訪談，以了解實際工作流程、未滿足的臨床需求和採購標準。這些訪談輔以對涵蓋致動器、感測器和控制系統的設備架構的技術審查，以及與神經病學、整形外科和運動醫學應用相關的臨床試驗終點和復健通訊協定的分析。

整合臨床、技術和商業性需求，以確定可在多種醫療環境中有效擴展的產品和服務策略。

總之，上下肢主動和被動訓練系統的市場環境正處於一個轉折點，技術成熟度、不斷演進的醫療服務模式和不斷變化的商業性動態在此交匯融合。能夠設計模組化、可升級平台並將其與強大的服務和分析解決方案相結合的製造商，將更有能力滿足醫院、診所和居家醫療機構的多樣化需求。關稅趨勢和供應鏈重組要求製造商謹慎選擇採購和生產環節，而臨床證據仍然是醫療保險報銷和廣泛應用的關鍵促進因素，尤其是在中風和脊髓復健等神經系統疾病領域。

目錄

第1章：序言

第2章調查方法

  • 研究設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查前提
  • 調查限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會地圖
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

8. 依設備類型分類的上肢及下肢主動及被動訓練系統市場

  • 非機器人
    • 等速運動裝置
    • 振動
  • 機器人
    • 末端執行器
    • 外骨骼

9. 上肢及下肢主動及被動訓練系統市場（依系統類型分類）

  • 積極的
  • 被動的

第10章 依治療類型分類的上肢及下肢主動及被動訓練系統市場

  • 運動功能
    • 精細動作功能
    • 大運動功能
  • 活動範圍
    • 主動輔助活動範圍訓練
    • 被動關節活動度練習
  • 肌力訓練
    • 下肢
    • 上肢

11. 依患者年齡層分類的上肢及下肢主動及被動訓練系統市場

  • 成人版
    • 18-45歲
    • 46-65歲
  • 老年人
    • 65-80
    • 80歲或以上
  • 兒童
    • 青春期
    • 新生

12. 上下肢主動和被動訓練系統市場（按組件分類）

  • 硬體
    • 致動器
    • 感應器
  • 服務
    • 安裝
    • 維護
  • 軟體
    • 分析
    • 控制系統

13. 依應用分類的上肢及下肢主動及被動訓練系統市場

  • 神經系統
    • 脊髓
    • 中風
  • 整形外科
    • 骨折復健
    • 術後
  • 運動醫學
    • 傷害預防
    • 績效改進

14. 依最終使用者分類的上肢及下肢主動及被動訓練系統市場

  • 診所
    • 一般的
    • 專業
  • 居家照護
  • 醫院
    • 門診部
    • 復健中心

15. 各區域上下肢主動及被動訓練系統市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

16. 上下肢主動與被動訓練系統市場（依組別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

17. 各國上肢及下肢主動及被動訓練系統市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第18章：美國上下肢主動與被動訓練系統市場

19. 中國主動與被動式上下肢訓練系統市場

第20章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • AlterG, Inc.
  • Bionik Laboratories Corp.
  • BTL Industries
  • Cyberdyne, Inc.
  • DJO Global
  • Ekso Bionics Holdings, Inc.
  • Fourier Intelligence
  • Hocoma AG
  • Kinova Inc.
  • Myomo, Inc.
  • Ottobock SE & Co. KGaA
  • Parker-Hannifin Corporation
  • Performance Health, Inc.
  • ReWalk Robotics Ltd.
  • Tyromotion GmbH
Product Code: MRR-AE420CB13AC0

The Upper & Lower Limb Active & Passive Training System Market was valued at USD 1.74 billion in 2025 and is projected to grow to USD 1.84 billion in 2026, with a CAGR of 5.86%, reaching USD 2.60 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.74 billion
Estimated Year [2026] USD 1.84 billion
Forecast Year [2032] USD 2.60 billion
CAGR (%) 5.86%

Framing the strategic context for upper and lower limb active and passive training systems to inform clinical pathways, procurement decisions, and innovation investment priorities

This executive summary provides a concise, actionable synthesis of the contemporary landscape for upper and lower limb active and passive training systems, designed for clinicians, procurement leaders, product innovators, and investors. The analysis frames device and system typologies alongside clinical and commercial drivers so stakeholders can rapidly orient strategy and prioritize near-term investments. The narrative integrates device-level distinctions-from non-robotic isokinetic machines and vibration systems to robotic end-effector and exoskeleton solutions-with system behavior across active and passive modalities, while maintaining focus on the operational realities faced by clinics, home care providers, and hospitals in their various subsegments.

The intent is to articulate the strategic inflection points shaping capital allocation, product development, and service models. To do so, the summary synthesizes technological advances in actuators, sensors, analytics and control systems with evolving therapy paradigms that span motor function, range of motion and strength training. In doing so, it remains attentive to patient segmentation by age group and clinical application, ensuring that the insights produced are clinically meaningful as well as commercially actionable. Transitional commentary connects macro trends to component-level implications so that readers can translate high-level intelligence into tactical plans for R&D prioritization, channel strategy, and clinical validation requirements.

How converging technological advances, service-centric models, and clinical evidence are redefining device design, deployment, and commercial value in limb rehabilitation

The market is being reshaped by convergent technological, clinical, and delivery-model shifts that are fundamentally altering how limb training systems are designed, purchased, and deployed. Advances in miniaturized actuators and high-fidelity sensors are enabling more compact hardware footprints that were previously confined to hospital environments, which in turn is accelerating demand for devices capable of reliable use in clinics and home care settings. Simultaneously, software-driven analytics and control systems are progressing from adjunctive features to core differentiators, enabling closed-loop therapies and remote monitoring that improve adherence and demonstrate measurable outcomes over time.

There is a clear movement from monolithic, single-use platforms toward modular solutions that can be configured across active and passive modalities to meet heterogeneous clinical protocols. This is accompanied by greater emphasis on human-centered design for exoskeletons and end-effector robots, reducing setup time and lowering training requirements for clinicians. Tele-rehabilitation and hybrid care pathways are gaining traction, and the integration of AI-assisted decision support into therapy planning is shifting the value proposition from hardware-alone to hardware-plus-software-and-services. As a result, service components such as installation and maintenance, along with advanced analytics, are accruing a larger role in lifetime product economics.

Clinically, the expanding evidence base for neurological applications-particularly stroke and spinal cord rehabilitation-is elevating the role of robotic assistance alongside established orthopedic and sports medicine indications. Equally important, demographic pressures and rising rates of chronic conditions are increasing volume and complexity across adult, geriatric, and pediatric cohorts, compelling providers to adopt scalable and interoperable solutions. Collectively, these transformative shifts require manufacturers and health systems to re-evaluate pricing strategies, training curricula, and reimbursement engagement to capture the full value enabled by integrated technology stacks.

Examining the 2025 tariff-induced shifts that reconfigured supply chains, procurement economics, and domestic manufacturing incentives for limb training systems

United States tariff changes implemented in 2025 have introduced a new set of constraints and opportunities across the supply chain for limb rehabilitation systems. The cumulative impact has been most acute for hardware-intensive subsegments where imported actuators, precision sensors, and specialized mechanical assemblies are common inputs. In response, procurement teams and manufacturers are recalibrating sourcing strategies, with some suppliers pursuing nearshoring or dual-sourcing to mitigate exposure and others renegotiating component specifications to reduce tariff burdens without compromising clinical performance.

The tariff environment has also influenced total cost of ownership assessments for end users. Hospitals and large clinics are increasingly evaluating not only acquisition cost but also lifecycle expenses such as maintenance, software subscriptions, and spare-part availability. For some device categories, price pass-through to purchasers has blurred the distinction between capital procurement and subscription-based models, accelerating interest in service agreements that bundle installation and maintenance and thereby provide predictable budgeting.

On the other hand, tariff-driven cost pressure has created competitive openings for domestic manufacturers and contract manufacturers capable of delivering compliant components at competitive cost points. This is most relevant for complex robotic solutions such as exoskeletons and end-effector devices, where a local supply base reduces risk and shortens lead times for installation and maintenance. In parallel, software and analytics vendors-less affected by physical tariff barriers-have positioned cloud-native platforms and remote support services as differentiators, helping customers offset hardware premium through improved utilization and outcome tracking. Overall, the tariff adjustments are accelerating structural shifts in procurement strategy, manufacturing footprint planning, and commercial contracting across the ecosystem.

A layered segmentation framework that connects device architectures, therapy modalities, end-user realities, and component ecosystems to prioritize R&D and commercialization pathways

A nuanced approach to segmentation illuminates where product development and commercial focus will deliver the greatest clinical and financial return. Device type distinctions separate non-robotic systems, represented by isokinetic machines and vibration platforms, from robotic solutions that fall into end-effector and exoskeleton architectures. Each device lineage carries different clinical workflows, capital intensity, and service needs, and they often serve complementary roles within multidisciplinary rehabilitation programs. System type segmentation, distinguishing active and passive modalities, further clarifies clinical application: active systems emphasize patient-initiated movement and motor relearning while passive systems are optimized for assisted range of motion and early post-operative protocols.

End-user segmentation reveals distinct adoption dynamics across clinics, which include general and specialty practices, home care environments, and hospitals that operate both outpatient departments and rehabilitation centers. Home care adoption favors compact hardware, remote monitoring software, and simplified maintenance pathways, whereas hospitals prioritize throughput, interoperability, and robust service agreements. Application-based segmentation highlights neurological use cases such as spinal cord and stroke rehabilitation, orthopedic pathways encompassing fracture rehabilitation and post-operative recovery, and sports medicine goals focused on injury prevention and performance enhancement. Therapy-type distinctions-spanning motor function with fine and gross motor modules, range of motion with active assisted and passive ROM strategies, and strength training differentiated into lower limb and upper limb focus-drive device control paradigms and outcome measures.

Patient age group segmentation underscores the need for adaptable interfaces and safety features across adult cohorts (18-45 and 46-65), geriatric populations (65-80 and 80+), and pediatric users (adolescents and neonatal). Component-level segmentation draws attention to hardware elements such as actuators and sensors, service offerings including installation and maintenance, and software capabilities in analytics and control systems that increasingly determine long-term value. When synthesized, these segmentation layers provide a framework to prioritize product roadmaps, clinical validation pathways, and commercialization strategies that match therapy objectives with end-user constraints and demographic realities.

Regional adoption dynamics and regulatory nuances across the Americas, Europe Middle East & Africa, and Asia-Pacific that dictate tailored commercialization and service strategies

Regional dynamics materially influence adoption patterns, regulatory priorities, and commercial models for limb training systems, requiring tailored strategies for market entry and scale. In the Americas, demand is shaped by integrated healthcare delivery systems, a high concentration of specialized rehabilitation centers, and growing interest in home-based care solutions. Payor models and reimbursement pathways in this region emphasize demonstrated clinical outcomes and cost-effectiveness, which elevates the importance of robust clinical evidence and long-term utilization metrics.

Europe, Middle East & Africa presents a heterogeneous landscape where regulatory harmonization within parts of Europe facilitates cross-border product registrations, while other markets emphasize localized procurement and clinician training. Reimbursement is variable, and adoption often depends on regional centers of excellence that can validate new technologies and generate referral pathways. In several markets, public health systems and budget cycles influence purchasing, prompting vendors to develop flexible financing models and local service capabilities.

Asia-Pacific is characterized by rapid adoption in urban centers, a growing private healthcare sector, and significant investments in digital health infrastructure. Regional manufacturing capabilities and supply-chain clusters in parts of Asia-Pacific can reduce time-to-market, but regulatory diversity and varying standards for clinical evidence require nuanced market entry approaches. Across all regions, adoption is strongly correlated with the maturity of home care ecosystems, the availability of trained therapists, and reimbursement frameworks that recognize the value of integrated software and service offerings. Understanding these regional subtleties enables manufacturers to calibrate product configurations, service commitments, and commercial partnerships for maximum impact.

Competitive differentiation driven by integrated technology stacks, service networks, and strategic partnerships that align clinical evidence with commercial scale

Competitive positioning in the limb training systems space is driven by differentiated technology stacks, clinical evidence, and the ability to deliver services that ensure high utilization and patient outcomes. Established leaders often combine rigorous clinical validation with comprehensive service networks and mature software platforms that support analytics and remote monitoring. At the same time, a new cohort of specialized innovators focuses on narrowing clinical indications or device form factors-such as compact home-use exoskeletons or modular end-effector units-that challenge incumbents on price, ease of use, and integration into tele-rehabilitation pathways.

Partnerships between hardware manufacturers and software analytics providers are increasingly common, enabling vendors to present integrated value propositions that encompass installation, maintenance, and outcome measurement. Additionally, some companies are vertically integrating supply chains to mitigate tariff exposure and reduce lead times for critical components like actuators and sensors. Investors and corporate development teams are tracking M&A activity that consolidates hardware, software, and service capabilities to accelerate scale and broaden the addressable market. For purchasers, vendor selection now weighs not only device performance but also the vendor's capacity to provide training, maintenance, and data-driven evidence of clinical and economic benefit over the product lifecycle.

Actionable strategic initiatives for manufacturers and providers to scale modular platforms, expand services, and mitigate tariff and supply-chain risks while demonstrating clinical value

Industry leaders should prioritize a set of actionable initiatives that align product development with clinical workflows and payor expectations, while also protecting margins in a changing tariff and supply-chain environment. First, invest in modular architectures that permit a base hardware platform to support both active and passive modalities and to accept incremental upgrades for actuators, sensors, and software capabilities. This approach reduces time-to-market for new therapy modules and allows for tailored configurations by end user, whether that is a specialty clinic, a hospital rehabilitation center, or a home care customer.

Second, expand service offerings that bundle installation, preventative maintenance, and remote analytics, converting one-time sales into recurring revenue streams and improving device uptime. Third, pursue nearshoring and dual-sourcing strategies for critical hardware components to mitigate tariff exposure while maintaining competitive lead times; simultaneously, explore partnerships with regional manufacturing hubs to lower logistics costs and improve responsiveness to local demand. Fourth, strengthen clinical evidence generation through targeted trials in neurological and orthopedic applications, ensuring publications emphasize functional outcomes that payors and procurement committees recognize. Lastly, tailor commercial models by region: prioritize outcome-based contracting and financing solutions in markets where reimbursement is constrained, and emphasize performance and interoperability in markets with advanced home care adoption. Collectively, these measures will help organizations capture share while addressing the operational realities of clinicians and procurement teams.

A transparent mixed-methods research approach combining expert interviews, technical device reviews, supply-chain mapping, and clinical literature triangulation to ensure robust insights

The research underpinning this executive summary combines qualitative expert engagement with rigorous secondary analysis and triangulation to ensure objective, actionable findings. Primary research involved structured interviews with clinicians, procurement leaders, device engineers, and health system administrators to capture real-world workflows, unmet clinical needs, and purchasing criteria. These interviews were complemented by technical reviews of device architectures-spanning actuators, sensors, and control systems-and by analysis of clinical trial endpoints and rehabilitation protocols relevant to neurological, orthopedic, and sports medicine applications.

Secondary research comprised a systematic review of peer-reviewed clinical literature, regulatory filings, and product technical specifications to validate performance claims and identify trends in user experience and safety features. Supply-chain mapping assessed component sourcing, tariff exposure, and manufacturing footprints to identify practical levers for cost and lead-time optimization. Findings were triangulated across data sources, and sensitivity checks were performed to ensure robustness of thematic conclusions. Finally, internal quality-control processes verified consistency and clarity of definitions used across segmentation dimensions such as device type, system type, end user, therapy type, patient age group, and component classification, ensuring that insights are reproducible and relevant for decision-making.

Synthesis of clinical, technological, and commercial imperatives that determine which product and service strategies will scale effectively across diverse care settings

In conclusion, the landscape for upper and lower limb active and passive training systems is at an inflection point where technological maturity, evolving care delivery models, and shifting commercial dynamics converge. Manufacturers that design modular, upgradeable platforms and pair them with robust service and analytics offerings will be best positioned to meet the divergent needs of hospitals, clinics, and home care settings. tariff dynamics and supply-chain reconfiguration require deliberate sourcing and manufacturing choices, while clinical evidence remains the critical enabler for reimbursement and broad adoption, particularly in neurological indications such as stroke and spinal cord rehabilitation.

Decision-makers should focus on aligning product roadmaps with therapy-specific requirements-whether fine motor recovery, passive range-of-motion protocols, or strength training for upper and lower limbs-while ensuring that interfaces and safety features address the needs of adult, geriatric, and pediatric populations. By integrating thoughtful regional strategies that reflect the unique market and regulatory conditions across the Americas, Europe Middle East & Africa, and Asia-Pacific, organizations can accelerate adoption and create differentiated value. Ultimately, success will hinge on the ability to translate device innovation into verifiable clinical outcomes and predictable operational economics for providers.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Upper & Lower Limb Active & Passive Training System Market, by Device Type

  • 8.1. Non Robotic
    • 8.1.1. Isokinetic Machines
    • 8.1.2. Vibration
  • 8.2. Robotic
    • 8.2.1. End Effector
    • 8.2.2. Exoskeleton

9. Upper & Lower Limb Active & Passive Training System Market, by System Type

  • 9.1. Active
  • 9.2. Passive

10. Upper & Lower Limb Active & Passive Training System Market, by Therapy Type

  • 10.1. Motor Function
    • 10.1.1. Fine Motor
    • 10.1.2. Gross Motor
  • 10.2. Range Of Motion
    • 10.2.1. Active Assisted ROM
    • 10.2.2. Passive ROM
  • 10.3. Strength Training
    • 10.3.1. Lower Limb
    • 10.3.2. Upper Limb

11. Upper & Lower Limb Active & Passive Training System Market, by Patient Age Group

  • 11.1. Adult
    • 11.1.1. 18-45
    • 11.1.2. 46-65
  • 11.2. Geriatric
    • 11.2.1. 65-80
    • 11.2.2. 80+
  • 11.3. Pediatric
    • 11.3.1. Adolescents
    • 11.3.2. Neonatal

12. Upper & Lower Limb Active & Passive Training System Market, by Component

  • 12.1. Hardware
    • 12.1.1. Actuators
    • 12.1.2. Sensors
  • 12.2. Service
    • 12.2.1. Installation
    • 12.2.2. Maintenance
  • 12.3. Software
    • 12.3.1. Analytics
    • 12.3.2. Control Systems

13. Upper & Lower Limb Active & Passive Training System Market, by Application

  • 13.1. Neurological
    • 13.1.1. Spinal Cord
    • 13.1.2. Stroke
  • 13.2. Orthopedic
    • 13.2.1. Fracture Rehab
    • 13.2.2. Post Op
  • 13.3. Sports Medicine
    • 13.3.1. Injury Prevention
    • 13.3.2. Performance Enhancement

14. Upper & Lower Limb Active & Passive Training System Market, by End User

  • 14.1. Clinics
    • 14.1.1. General
    • 14.1.2. Specialty
  • 14.2. Home Care
  • 14.3. Hospitals
    • 14.3.1. Outpatient Department
    • 14.3.2. Rehabilitation Center

15. Upper & Lower Limb Active & Passive Training System Market, by Region

  • 15.1. Americas
    • 15.1.1. North America
    • 15.1.2. Latin America
  • 15.2. Europe, Middle East & Africa
    • 15.2.1. Europe
    • 15.2.2. Middle East
    • 15.2.3. Africa
  • 15.3. Asia-Pacific

16. Upper & Lower Limb Active & Passive Training System Market, by Group

  • 16.1. ASEAN
  • 16.2. GCC
  • 16.3. European Union
  • 16.4. BRICS
  • 16.5. G7
  • 16.6. NATO

17. Upper & Lower Limb Active & Passive Training System Market, by Country

  • 17.1. United States
  • 17.2. Canada
  • 17.3. Mexico
  • 17.4. Brazil
  • 17.5. United Kingdom
  • 17.6. Germany
  • 17.7. France
  • 17.8. Russia
  • 17.9. Italy
  • 17.10. Spain
  • 17.11. China
  • 17.12. India
  • 17.13. Japan
  • 17.14. Australia
  • 17.15. South Korea

18. United States Upper & Lower Limb Active & Passive Training System Market

19. China Upper & Lower Limb Active & Passive Training System Market

20. Competitive Landscape

  • 20.1. Market Concentration Analysis, 2025
    • 20.1.1. Concentration Ratio (CR)
    • 20.1.2. Herfindahl Hirschman Index (HHI)
  • 20.2. Recent Developments & Impact Analysis, 2025
  • 20.3. Product Portfolio Analysis, 2025
  • 20.4. Benchmarking Analysis, 2025
  • 20.5. AlterG, Inc.
  • 20.6. Bionik Laboratories Corp.
  • 20.7. BTL Industries
  • 20.8. Cyberdyne, Inc.
  • 20.9. DJO Global
  • 20.10. Ekso Bionics Holdings, Inc.
  • 20.11. Fourier Intelligence
  • 20.12. Hocoma AG
  • 20.13. Kinova Inc.
  • 20.14. Myomo, Inc.
  • 20.15. Ottobock SE & Co. KGaA
  • 20.16. Parker-Hannifin Corporation
  • 20.17. Performance Health, Inc.
  • 20.18. ReWalk Robotics Ltd.
  • 20.19. Tyromotion GmbH

LIST OF FIGURES

  • FIGURE 1. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY DEVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY SYSTEM TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY THERAPY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY PATIENT AGE GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY COMPONENT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. UNITED STATES UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 15. CHINA UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY NON ROBOTIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY NON ROBOTIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY NON ROBOTIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY NON ROBOTIC, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY ISOKINETIC MACHINES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY ISOKINETIC MACHINES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY ISOKINETIC MACHINES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY VIBRATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY VIBRATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY VIBRATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY ROBOTIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY ROBOTIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY ROBOTIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY ROBOTIC, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY END EFFECTOR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY END EFFECTOR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY END EFFECTOR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY EXOSKELETON, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY EXOSKELETON, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY EXOSKELETON, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY ACTIVE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY ACTIVE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY ACTIVE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY PASSIVE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY PASSIVE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY PASSIVE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY MOTOR FUNCTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY MOTOR FUNCTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY MOTOR FUNCTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY MOTOR FUNCTION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY FINE MOTOR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY FINE MOTOR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY FINE MOTOR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY GROSS MOTOR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY GROSS MOTOR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY GROSS MOTOR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY RANGE OF MOTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY RANGE OF MOTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY RANGE OF MOTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY RANGE OF MOTION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY ACTIVE ASSISTED ROM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY ACTIVE ASSISTED ROM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY ACTIVE ASSISTED ROM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY PASSIVE ROM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY PASSIVE ROM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY PASSIVE ROM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY STRENGTH TRAINING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY STRENGTH TRAINING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY STRENGTH TRAINING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY STRENGTH TRAINING, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY LOWER LIMB, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY LOWER LIMB, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY LOWER LIMB, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY UPPER LIMB, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY UPPER LIMB, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY UPPER LIMB, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY ADULT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY ADULT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY ADULT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY ADULT, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY 18-45, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY 18-45, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY 18-45, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY 46-65, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY 46-65, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY 46-65, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY GERIATRIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY GERIATRIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY GERIATRIC, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY 65-80, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY 65-80, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY 65-80, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY 80+, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY 80+, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY 80+, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY PEDIATRIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY PEDIATRIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY PEDIATRIC, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY ADOLESCENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY ADOLESCENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY ADOLESCENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY NEONATAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY NEONATAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY NEONATAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY HARDWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY HARDWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY HARDWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY ACTUATORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY ACTUATORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY ACTUATORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY SENSORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY SENSORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY SENSORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY SERVICE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY SERVICE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY SERVICE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY SERVICE, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY INSTALLATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY INSTALLATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY INSTALLATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY MAINTENANCE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY MAINTENANCE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY MAINTENANCE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY ANALYTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY ANALYTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY ANALYTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY CONTROL SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY CONTROL SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY CONTROL SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY NEUROLOGICAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY NEUROLOGICAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY NEUROLOGICAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY NEUROLOGICAL, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY SPINAL CORD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY SPINAL CORD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY SPINAL CORD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY STROKE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY STROKE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY STROKE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY ORTHOPEDIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY ORTHOPEDIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 136. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY ORTHOPEDIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY FRACTURE REHAB, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 139. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY FRACTURE REHAB, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY FRACTURE REHAB, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 141. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY POST OP, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 142. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY POST OP, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 143. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY POST OP, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 144. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY SPORTS MEDICINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 145. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY SPORTS MEDICINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 146. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY SPORTS MEDICINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 147. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY SPORTS MEDICINE, 2018-2032 (USD MILLION)
  • TABLE 148. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY INJURY PREVENTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 149. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY INJURY PREVENTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 150. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY INJURY PREVENTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 151. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY PERFORMANCE ENHANCEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 152. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY PERFORMANCE ENHANCEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 153. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY PERFORMANCE ENHANCEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 154. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 155. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 156. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 157. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 158. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 159. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY GENERAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 160. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY GENERAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 161. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY GENERAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 162. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY SPECIALTY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 163. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY SPECIALTY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 164. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY SPECIALTY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 165. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY HOME CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 166. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY HOME CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 167. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY HOME CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 168. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 169. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 170. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 171. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 172. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY OUTPATIENT DEPARTMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 173. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY OUTPATIENT DEPARTMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 174. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY OUTPATIENT DEPARTMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 175. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY REHABILITATION CENTER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 176. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY REHABILITATION CENTER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 177. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY REHABILITATION CENTER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 178. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 179. AMERICAS UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 180. AMERICAS UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 181. AMERICAS UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY NON ROBOTIC, 2018-2032 (USD MILLION)
  • TABLE 182. AMERICAS UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY ROBOTIC, 2018-2032 (USD MILLION)
  • TABLE 183. AMERICAS UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 184. AMERICAS UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 185. AMERICAS UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY MOTOR FUNCTION, 2018-2032 (USD MILLION)
  • TABLE 186. AMERICAS UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY RANGE OF MOTION, 2018-2032 (USD MILLION)
  • TABLE 187. AMERICAS UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY STRENGTH TRAINING, 2018-2032 (USD MILLION)
  • TABLE 188. AMERICAS UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 189. AMERICAS UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY ADULT, 2018-2032 (USD MILLION)
  • TABLE 190. AMERICAS UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY GERIATRIC, 2018-2032 (USD MILLION)
  • TABLE 191. AMERICAS UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY PEDIATRIC, 2018-2032 (USD MILLION)
  • TABLE 192. AMERICAS UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 193. AMERICAS UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 194. AMERICAS UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY SERVICE, 2018-2032 (USD MILLION)
  • TABLE 195. AMERICAS UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 196. AMERICAS UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 197. AMERICAS UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY NEUROLOGICAL, 2018-2032 (USD MILLION)
  • TABLE 198. AMERICAS UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 199. AMERICAS UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY SPORTS MEDICINE, 2018-2032 (USD MILLION)
  • TABLE 200. AMERICAS UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 201. AMERICAS UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 202. AMERICAS UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 203. NORTH AMERICA UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 204. NORTH AMERICA UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 205. NORTH AMERICA UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY NON ROBOTIC, 2018-2032 (USD MILLION)
  • TABLE 206. NORTH AMERICA UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY ROBOTIC, 2018-2032 (USD MILLION)
  • TABLE 207. NORTH AMERICA UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 208. NORTH AMERICA UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 209. NORTH AMERICA UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY MOTOR FUNCTION, 2018-2032 (USD MILLION)
  • TABLE 210. NORTH AMERICA UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY RANGE OF MOTION, 2018-2032 (USD MILLION)
  • TABLE 211. NORTH AMERICA UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY STRENGTH TRAINING, 2018-2032 (USD MILLION)
  • TABLE 212. NORTH AMERICA UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 213. NORTH AMERICA UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY ADULT, 2018-2032 (USD MILLION)
  • TABLE 214. NORTH AMERICA UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY GERIATRIC, 2018-2032 (USD MILLION)
  • TABLE 215. NORTH AMERICA UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY PEDIATRIC, 2018-2032 (USD MILLION)
  • TABLE 216. NORTH AMERICA UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 217. NORTH AMERICA UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 218. NORTH AMERICA UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY SERVICE, 2018-2032 (USD MILLION)
  • TABLE 219. NORTH AMERICA UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 220. NORTH AMERICA UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 221. NORTH AMERICA UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY NEUROLOGICAL, 2018-2032 (USD MILLION)
  • TABLE 222. NORTH AMERICA UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 223. NORTH AMERICA UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY SPORTS MEDICINE, 2018-2032 (USD MILLION)
  • TABLE 224. NORTH AMERICA UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 225. NORTH AMERICA UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 226. NORTH AMERICA UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 227. LATIN AMERICA UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 228. LATIN AMERICA UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 229. LATIN AMERICA UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY NON ROBOTIC, 2018-2032 (USD MILLION)
  • TABLE 230. LATIN AMERICA UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY ROBOTIC, 2018-2032 (USD MILLION)
  • TABLE 231. LATIN AMERICA UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 232. LATIN AMERICA UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 233. LATIN AMERICA UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY MOTOR FUNCTION, 2018-2032 (USD MILLION)
  • TABLE 234. LATIN AMERICA UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY RANGE OF MOTION, 2018-2032 (USD MILLION)
  • TABLE 235. LATIN AMERICA UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY STRENGTH TRAINING, 2018-2032 (USD MILLION)
  • TABLE 236. LATIN AMERICA UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 237. LATIN AMERICA UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY ADULT, 2018-2032 (USD MILLION)
  • TABLE 238. LATIN AMERICA UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY GERIATRIC, 2018-2032 (USD MILLION)
  • TABLE 239. LATIN AMERICA UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY PEDIATRIC, 2018-2032 (USD MILLION)
  • TABLE 240. LATIN AMERICA UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 241. LATIN AMERICA UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 242. LATIN AMERICA UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY SERVICE, 2018-2032 (USD MILLION)
  • TABLE 243. LATIN AMERICA UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 244. LATIN AMERICA UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 245. LATIN AMERICA UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY NEUROLOGICAL, 2018-2032 (USD MILLION)
  • TABLE 246. LATIN AMERICA UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 247. LATIN AMERICA UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY SPORTS MEDICINE, 2018-2032 (USD MILLION)
  • TABLE 248. LATIN AMERICA UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 249. LATIN AMERICA UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 250. LATIN AMERICA UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 251. EUROPE, MIDDLE EAST & AFRICA UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 252. EUROPE, MIDDLE EAST & AFRICA UP